Salbutamol 10 mg is an oral salbutamol tablet manufactured by Dragon Pharma, dosed at 10 mg per tablet in a 100-tablet package.
Salbutamol 10 mg contains salbutamol, a short-acting, selective beta-2 adrenergic receptor agonist. Salbutamol works by stimulating beta-2 receptors, which are predominantly found in bronchial smooth muscle, skeletal muscle, and adipose tissue. This stimulation causes smooth muscle relaxation and bronchodilation, which is the basis for its medical use in asthma and COPD. In non-medical bodybuilding contexts, salbutamol is commonly referenced for its thermogenic and potential muscle-preserving properties, though such use falls outside approved medical indications.
Salbutamol's selectivity for beta-2 receptors is approximately 29 times greater than for beta-1 receptors, which gives it higher specificity for pulmonary and skeletal muscle beta receptors compared to cardiac beta-1 receptors. Following oral ingestion, salbutamol reaches peak systemic concentrations within 1 to 3 hours, and its duration of action is typically 4 to 6 hours. The terminal elimination half-life is approximately 4 to 6 hours.
In bodybuilding circles, salbutamol is sometimes discussed as an alternative to clenbuterol for fat loss and performance enhancement. A 2025 study investigating high-dose oral salbutamol during resistance training noted that the regimen used (16 mg daily) "resembles the regimen used within bodybuilding" and exceeds therapeutic inhaled doses by a significant margin. However, this study also found that high-dose salbutamol did not augment lean mass gains and was associated with cardiac remodeling effects. The 10 mg strength of Salbutamol 10 mg aligns with the oral doses used in some non-medical contexts, though it exceeds standard therapeutic oral dosing.
Salbutamol 10 mg is supplied as an oral tablet containing 10 mg of salbutamol per tablet. Oral administration allows for convenient dosing without the need for inhalation equipment.
Salbutamol is a short-acting beta-2 adrenergic receptor agonist that produces bronchodilation and has metabolic effects on skeletal muscle and adipose tissue.
Salbutamol belongs to the class of short-acting beta-2 adrenergic agonists (SABAs). Its primary mechanism involves binding to and activating beta-2 adrenergic receptors, which are G-protein coupled receptors found in high density in bronchial smooth muscle, skeletal muscle, and adipocytes. Activation of these receptors leads to increased intracellular cyclic adenosine monophosphate (cAMP), which in smooth muscle causes relaxation and bronchodilation, and in skeletal muscle and adipose tissue influences metabolic pathways.
The pharmacokinetics of oral salbutamol are characterized by rapid absorption from the gastrointestinal tract. Peak plasma concentrations are reached within 1 to 3 hours after oral ingestion, with a duration of action of approximately 4 to 6 hours. The drug undergoes extensive first-pass metabolism in the liver, primarily to the inactive phenolic sulfate conjugate, and both unchanged drug and conjugate are excreted primarily in the urine.
In the context of bodybuilding, salbutamol's appeal lies in its potential effects on body composition. Beta-2 adrenergic stimulation has been shown to promote lipolysis and thermogenesis, and chronic treatment may induce phenotypic changes in white adipocytes toward greater thermogenic capacity. Salbutamol also has anabolic effects on skeletal muscle in animal models, though evidence for significant muscle hypertrophy in humans at tolerated doses is limited. A 2025 randomized controlled trial found that 16 mg daily salbutamol during 11 weeks of resistance training did not augment lean mass gains compared to placebo.
Salbutamol has a terminal elimination half-life of approximately 4 to 6 hours following oral administration. This supports the multiple daily dosing regimens commonly referenced in both clinical and non-medical contexts.
Dragon Pharma offers a range of compounds relevant to fat loss and performance enhancement. Salbutamol 10 mg is positioned as a beta-2 agonist option, complementing other products used in cutting phases or body recomposition goals.
For alternative beta-2 agonist options, Dragon Pharma offers Clenbuterol, which is a longer-acting beta-2 agonist commonly referenced in bodybuilding contexts. For thyroid hormone support during cutting, T3 and T4 are also available. For stimulant-based fat loss approaches, Sibutramine is an additional option.
The information below is provided for educational reference only. Salbutamol is a prescription medication; medical use requires appropriate diagnosis, clinical supervision and ongoing monitoring. Non-medical use falls outside approved indications.
In medical practice, oral salbutamol for asthma or bronchospasm is typically dosed at 4 mg three to four times daily in adults, with gradual increases up to a maximum of 8 mg three to four times daily if needed. In non-medical bodybuilding contexts, salbutamol is commonly referenced at higher doses, with one study using 16 mg daily as a single dose to resemble regimens used in the bodybuilding community. Such use falls outside approved medical indications and exceeds therapeutic dosing.
| Use Case | Common Reference Range | Frequency |
|---|---|---|
| Medical (asthma/bronchospasm) | 4–8 mg | 3–4 times daily |
| Bodybuilding (non-medical, fat loss) | 8–16 mg | Once daily or divided |
| Bodybuilding (non-medical, performance) | 16 mg | Once daily |
Salbutamol 10 mg tablets exceed the standard 4 mg medical dose, and non-medical protocols often involve doses that are significantly higher than therapeutic recommendations.
Salbutamol is not an anabolic compound and is not typically stacked for muscle-building purposes. In non-medical bodybuilding contexts, it is most commonly referenced during cutting phases for its potential thermogenic effects, sometimes alongside other fat loss agents. Dragon Pharma offers Clenbuterol as an alternative beta-2 agonist that is longer-acting and more commonly discussed in bodybuilding circles. For thyroid support during cutting, T3 is another option.
Because salbutamol and other beta-2 agonists can cause cardiac stimulation and potentially interact with other compounds, cycle structure and support compounds should be considered in the context of individual experience, health status, and bloodwork where possible.
Oral salbutamol at therapeutic doses commonly causes tremor (20% incidence) and nervousness (20% incidence), along with headache, tachycardia, and palpitations. At the higher doses referenced in non-medical contexts, these effects may be more pronounced. A 2025 study using 16 mg daily found that high-dose salbutamol was associated with cardiac remodeling effects, including increased left ventricular mass and altered diastolic function.
Salbutamol can also cause hypokalemia (decreased serum potassium), which is usually transient but may produce adverse cardiovascular effects, especially when the recommended dose is exceeded. Muscle cramps have been reported in approximately 3% of patients taking oral salbutamol.
Salbutamol is not part of standard post-cycle therapy protocols, which focus on restoring endogenous testosterone production. PCT compounds such as Clomid and Nolvadex address the hypothalamic-pituitary-gonadal axis rather than beta-adrenergic signaling. Salbutamol's role is generally limited to on-cycle fat loss or performance applications.
Dosing strategies and support protocols should be adjusted based on experience level and bloodwork where possible. The information above is for educational reference and does not constitute medical advice.
Salbutamol is a prescription beta-2 agonist that can affect cardiovascular, metabolic, and respiratory function. Medical use requires appropriate diagnosis, clinical supervision and ongoing monitoring.
Salbutamol tablets are indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease. Use of salbutamol at supraphysiologic doses for bodybuilding or performance enhancement falls outside approved indications and can increase exposure to beta-adrenergic adverse effects.
Non-medical use of salbutamol for fat loss or performance enhancement during bodybuilding cycles is not approved by regulatory agencies and may carry additional health risks. Product quality does not establish that non-medical use is safe or appropriate.
In clinical trials, the most frequent adverse reactions to oral albuterol tablets were nervousness (20%) and tremor (20%), followed by headache (7%), tachycardia (5%), palpitations (5%), and muscle cramps (3%). These effects are dose-dependent and may be more pronounced at the higher doses referenced in non-medical contexts.
Salbutamol can produce clinically significant cardiovascular effects, including changes in pulse rate and blood pressure, and ECG changes such as flattening of the T wave and prolongation of the QTc interval. A 2025 study using 16 mg daily salbutamol during resistance training found cardiac remodeling effects, including increased left ventricular mass.
Beta-agonists may produce significant hypokalemia through intracellular shunting, which has the potential to produce adverse cardiovascular effects. The decrease is usually transient and does not require supplementation in most cases. Salbutamol should be used with caution in patients with cardiovascular disorders, convulsive disorders, hyperthyroidism, or diabetes mellitus.
Salbutamol tablets are contraindicated in patients with a history of hypersensitivity to albuterol or any of its components. Salbutamol should be used with caution in patients with coronary insufficiency, cardiac arrhythmias, hypertension, hyperthyroidism, or diabetes mellitus. Large doses of intravenous albuterol have been reported to aggravate preexisting diabetes mellitus and ketoacidosis.
Medically supervised oral salbutamol therapy typically involves assessment of treatment response and monitoring for adverse effects such as tremor, tachycardia, and changes in blood pressure. In the context of asthma, deterioration of symptoms or need for increased dosing may indicate destabilization and require medical re-evaluation.
Keep the product securely stored and protected from conditions that could compromise the tablets or packaging. Inspect the product before use and do not use if it appears damaged or otherwise abnormal. Keep all medications out of the reach of children.
Salbutamol 10 mg is supplied through the official Dragon Pharma distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the official Dragon Pharma distribution chain.
To verify your Salbutamol 10 mg product, use the security code on the packaging and cross-check it on the Dragon Pharma official site. Official Dragon Pharma presentation and original packaging help reinforce product legitimacy and buyer confidence.
Proper storage conditions help preserve tablet integrity and stability throughout shelf life.
Store in a cool, dry place at controlled room temperature (15–25°C). Protect from excessive heat, moisture, and direct light. Keep the tablets in their original packaging until use.
Do not use if the packaging appears damaged or if the tablets show signs of deterioration. Keep out of reach of children.
Answers to common questions about Salbutamol 10 mg, salbutamol, beta-2 agonists, product strength and non-medical reference points.
Salbutamol 10 mg contains salbutamol, a beta-2 agonist. In medical practice, oral salbutamol is used for the relief of bronchospasm in asthma and other reversible obstructive airway diseases. In non-medical bodybuilding contexts, it is occasionally referenced for its thermogenic and potential performance-enhancing properties. Such use falls outside approved medical indications.
In medical practice, oral salbutamol is typically dosed at 4 mg three to four times daily. In non-medical bodybuilding contexts, doses as high as 16 mg daily have been referenced, which significantly exceeds therapeutic recommendations. Dosing should be individualized and is not a substitute for medical guidance.
Salbutamol is not part of standard post-cycle therapy, which focuses on restoring endogenous testosterone production. PCT compounds like Clomid and Nolvadex address the hypothalamic-pituitary-gonadal axis rather than beta-adrenergic signaling. Salbutamol's role is generally limited to on-cycle fat loss or performance applications.
Salbutamol stimulates beta-2 adrenergic receptors, which are found in bronchial smooth muscle, skeletal muscle, and adipose tissue. This causes bronchodilation by relaxing airway smooth muscle and also influences metabolic pathways related to lipolysis and thermogenesis. It is a short-acting beta-2 agonist with a duration of action of 4 to 6 hours.
Following oral ingestion, salbutamol reaches peak systemic concentrations within 1 to 3 hours. In clinical trials of oral albuterol tablets, the onset of improvement in pulmonary function was noted within 30 minutes, with peak improvement occurring between 2 and 3 hours. The duration of action is typically 4 to 6 hours.
There is no single beta-2 agonist that is universally best for fat loss. Salbutamol is a short-acting option with a duration of action of 4 to 6 hours. Clenbuterol is a longer-acting beta-2 agonist that is more commonly referenced in bodybuilding contexts. The appropriate choice depends on individual goals and circumstances.
Salbutamol and Clenbuterol are both beta-2 agonists, but they differ in duration of action and potency. Salbutamol is short-acting with a half-life of 4 to 6 hours, while clenbuterol has a much longer half-life and is more commonly discussed in bodybuilding for fat loss. Both carry similar cardiovascular risks at high doses.
Salbutamol and T3 work through completely different mechanisms for fat loss. Salbutamol is a beta-2 adrenergic agonist that stimulates lipolysis and thermogenesis, while T3 is a thyroid hormone that increases metabolic rate. They are sometimes referenced together in cutting contexts, though each carries distinct risks and considerations.
In medical practice, 10 mg is above the typical initial oral dose of 4 mg, though it is within the range that can be used at higher therapeutic doses (up to 8 mg three to four times daily). In non-medical bodybuilding contexts, 10 mg is a moderate dose relative to the higher amounts (up to 16 mg daily) that have been referenced in some protocols. The 10 mg strength allows for flexible dosing.
Salbutamol 10 mg is labeled at 10 mg of salbutamol per tablet. It is supplied in a 100-tablet package, giving 1,000 mg of total labeled salbutamol content.
Yes. Salbutamol can produce clinically significant cardiovascular effects, including increased heart rate, palpitations, and ECG changes. A 2025 study using 16 mg daily during resistance training found cardiac remodeling effects, including increased left ventricular mass. Salbutamol should be used with caution in individuals with cardiovascular disorders, and high doses should be avoided.
Yes. Muscle cramps were reported in approximately 3% of patients taking oral albuterol tablets in clinical trials. This side effect is thought to be related to beta-2 agonist effects on skeletal muscle and electrolyte shifts, particularly potassium. The cramps are typically dose-dependent and may resolve with dose reduction.